Reaction
Anal Ulcer reporting signals
As of the last recalculation, Anal Ulcer appears in 805 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is EVEROLIMUS TABLETS (PRR 34.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Everolimus Tablets | 22 | 34.8 | 34.9 |
| Atovaquone | 10 | 32.5 | 32.5 |
| Valganciclovir Hydrochloride Powder, | 15 | 32.4 | 32.4 |
| Pegaspargase | 13 | 27.9 | 27.9 |
| Valganciclovir | 16 | 22.4 | 22.4 |
| Valganciclovir Hydrochloride | 16 | 22.4 | 22.4 |
| Everolimus | 31 | 16.3 | 16.4 |
| Sunitinib Malate | 24 | 16.2 | 16.2 |
| Vincristine Sulfate | 18 | 16.2 | 16.2 |
| Sorafenib | 12 | 15.2 | 15.2 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 13 | 14.6 | 14.6 |
| Vedolizumab | 38 | 11.9 | 11.9 |
| Regorafenib | 5 | 11.2 | 11.2 |
| Pemetrexed | 8 | 9.7 | 9.7 |
| Obinutuzumab | 6 | 9.5 | 9.5 |
| Cabozantinib | 16 | 8.8 | 8.8 |
| Carfilzomib | 8 | 7.4 | 7.4 |
| Trifluridine And Tipiracil | 3 | 7.3 | 7.3 |